2 ． Overview of the DeSC Database and Utilization for Clinical Epidemiology and Pharmacoepidemiology Research

Akira OKADA; Hideo YASUNAGA

Return

2 ． Overview of the DeSC Database and Utilization for Clinical Epidemiology and Pharmacoepidemiology Research

VernacularTitle:2 ．DeSC データベースの概要と臨床疫学・薬剤疫学研究への活用
Author: Akira OKADA ¹ ; Hideo YASUNAGA ²
Author Information

1. Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Japan
2. Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Japan
Keywords: real-world data; DeSC database; administrative claims database; clinical epidemiology; pharmacoepidemiology
From:Japanese Journal of Pharmacoepidemiology 2022;27(1):11-18
CountryJapan
Language:Japanese
Abstract: Studies using real-world data are recently increasing worldwide. Various types of real-world data are available in Japan. Administrative claims databases include the National Database (NDB) and other types of databases including several commercially available databases. This article describes the DeSC database, newly constructed by DeSC Healthcare Co., Ltd. in 2020. One of the features of the DeSC database is that it includes data from the National Health Insurance, Health Insurance, and Advanced Elderly Medical Service System. In the present article, we referred to our previous study on population representativeness of the DeSC database and explained its overview. Estimated prevalence of some diseases were described for each type of insurance. Furthermore, we discussed the use of the DeSC database for clinical epidemiology and pharmacoepidemiology research.